bluuebunny/crossref_metadata_2025_split huggingface dataset:
Spatially Explicit Parameterization of a Terrestrial Ecosystem Model and Its Application to the Quantification of Carbon Dynamics of Forest Ecosystems in the Conterminous United States
Authors: Chen Min , Zhuang Qianlai 
Published: April 2012

Abstract
The authors use a spatially explicit parameterization method and the Terrestrial Ecosystem Model (TEM) to quantify the carbon dynamics of forest ecosystems in the conterminous United States. Six key parameters that govern the rates of carbon and nitrogen dynamics in TEM are selected for calibration. Spatially explicit data for carbon and nitrogen pools and fluxes are used to calibrate the six key parameters to more adequately account for the spatial heterogeneity of ecosystems in estimating regional carbon dynamics. The authors find that a spatially explicit parameterization results in vastly different carbon exchange rates relative to a parameterization conducted for representative ecosystem sites. The new parameterization method estimates that the net ecosystem production (NEP), the annual gross primary production (GPP), and the net primary production (NPP) of the regional forest ecosystems are 61% (0.02 Pg C; 1 Pg = 1015 g) higher and 2% (0.11 Pg C) and 19% (0.45 Pg C) lower, respectively, than the values obtained using the traditional parameterization method for the period 1948–2000. The estimated vegetation carbon and soil organic carbon pool sizes are 51% (18.73 Pg C) lower and 29% (7.40 Pg C) higher. This study suggests that, to more adequately quantify regional carbon dynamics, spatial data for carbon and nitrogen pools and fluxes should be developed and used with the spatially explicit parameterization method.
Transport of Stratospheric Air Masses to the Nepal Climate Observatory–Pyramid (Himalaya; 5079 m MSL): A Synoptic-Scale Investigation
Authors: Bracci A. , Cristofanelli P. , Sprenger M. , Bonafè U. , Calzolari F. , Duchi R. , Laj P. , Marinoni A. , Roccato F. , Vuillermoz E. , Bonasoni P. 
Published: April 2012

AbstractThis work analyzes and classifies stratospheric airmass transport events (ST) detected at the Nepal Climate Observatory–Pyramid (NCO-P; 27°57′N, 86°48′E, 5079 m MSL) Global Atmospheric Watch–World Meteorological Organization station from March 2006 to February 2008. For this purpose, in situ ozone (O3), meteorological parameters (atmospheric pressure and relative humidity), and black carbon (BC) are analyzed. The paper describes the synoptic-scale meteorological scenarios that are able to favor the development of ST over the southern Himalaya, by analyzing the meteorological fields provided by the ECMWF model (geopotential height, wind speed, and potential vorticity), satellite Ozone Monitoring Instrument data (total column ozone), and three-dimensional back trajectories calculated with the Lagrangian Analysis Tool (LAGRANTO) model. The study, which represents the first “continuous” classification of ST in the southern Himalaya, permitted classification of 94% of ST days within four synoptic-scale scenarios: stratospheric potential vorticity structures (PVS), subtropical jet stream (SJS), quasi-stationary ridges (QSR), and monsoon depressions (MD). SJS and PVS were the most frequent scenarios (48% and 30% of occurrences, respectively), QSR occurred for 12% of the ST days, and MD were detected only during the monsoon season (3%). SJS and PVS scenarios presented a peak frequency during the nonmonsoon seasons, when the jet stream and westerly disturbances influence atmospheric circulation over the southern Himalaya. During the identified ST, significant variations of O3 (+24%) and BC (−56%) were recorded relative to the averaged 2-yr mean values. On average, PVS and SJS were the most effective synoptic-scale scenarios in modifying the O3 and BC levels at NCO-P from postmonsoon to premonsoon seasons, and ST is one of the leading processes in defining the “background” BC variability at NCO-P.
Bipolar II disorder in rural New South Wales
Authors: Robertson Andrew , de Moore Greg , Boyce Philip 
Published: April 2012

Objective: To determine the frequency with which bipolar II disorder (BD II) was diagnosed in clinics held in four rural towns in New South Wales (NSW). Method: A retrospective case file audit was conducted for patients referred for psychiatric assessment and treatment in four towns in rural NSW over a period of two years and nine months. Results: Of 559 patients seen for the first time during the study period, 113 (20.2%) were diagnosed with BD II, and of these this diagnosis was made for the first time in 69 patients (61%). Associated clinical findings in BD II patients are presented and a comparison is made with patients with non-bipolar depression seen during the same period. Conclusion: BD II was commonly seen in these rural clinics, and appears to be often under-diagnosed in general practice, as has been found to be the case in urban centres. This is seen as a serious public health problem, which needs to be addressed by educational steps directed at general practitioners (GPs), mental health clinicians, and perhaps also the general public.
Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation
Authors: Gopal Ajay K. , Ramchandren Radhakrishnan , O'Connor Owen A. , Berryman Robert B. , Advani Ranjana H. , Chen Robert , Smith Scott E. , Cooper Maureen , Rothe Achim , Matous Jeffrey V. , Grove Laurie E. , Zain Jasmine 
Published: April 2012

Abstract
Hodgkin lymphoma (HL) relapsing after allogeneic stem cell transplantation (alloSCT) presents a major clinical challenge. In the present investigation, we evaluated brentuximab vedotin, a CD30-directed Ab-drug conjugate, in 25 HL patients (median age, 32 years; range, 20-56) with recurrent disease after alloSCT (11 unrelated donors). Patients were > 100 days after alloSCT, had no active GVHD, and received a median of 9 (range, 5-19) prior regimens. Nineteen (76%) had refractory disease immediately before enrollment. Patients received 1.2 or 1.8 mg/kg of brentuximab vedotin IV every 3 weeks (median, 8 cycles; range, 1-16). Overall and complete response rates were 50% and 38%, respectively, among 24 evaluable patients. Median time to response was 8.1 weeks, median progression-free survival was 7.8 months, and the median overall survival was not reached. Cough, fatigue, and pyrexia (52% each), nausea and peripheral sensory neuropathy (48% each), and dyspnea (40%) were the most frequent adverse events. The most common adverse events ≥ grade 3 were neutropenia (24%), anemia (20%), thrombocytopenia (16%), and hyperglycemia (12%). Cytomegalovirus was detected in 5 patients (potentially clinically significant in 1). These results support the potential utility of brentuximab vedotin for selected patients with HL relapsing after alloSCT. These trials are registered with www.clinicaltrials.gov as NCT01026233, NCT01026415, and NCT00947856.
Evidence for local dendritic cell activation in pulmonary sarcoidosis
Authors: Berge Bregje Ten , KleinJan Alex , Muskens Femke , Hammad Hamida , Hoogsteden Henk C , Hendriks Rudi W , Lambrecht Bart N , Van den Blink Bernt 
Published: April 2012

Abstract

Background
Sarcoidosis is a granulomatous disease characterized by a seemingly exaggerated immune response against a difficult to discern antigen. Dendritic cells (DCs) are pivotal antigen presenting cells thought to play an important role in the pathogenesis. Paradoxically, decreased DC immune reactivity was reported in blood samples from pulmonary sarcoidosis patients. However, functional data on lung DCs in sarcoidosis are lacking. We hypothesized that at the site of disease DCs are mature, immunocompetent and involved in granuloma formation.

Methods
We analyzed myeloid DCs (mDCs) and plasmacytoid DCs (pDCs) in broncho-alveolar lavage (BAL) and blood from newly diagnosed, untreated pulmonary sarcoidosis patients and healthy controls using 9-color flowcytometry. DCs, isolated from BAL using flowcytometric sorting (mDCs) or cultured from monocytes (mo-DCs), were functionally assessed in a mixed leukocyte reaction with naïve allogeneic CD4+ T cells. Using Immunohistochemistry, location and activation status of CD11c+DCs was assessed in mucosal airway biopsies.

Results
mDCs in BAL, but not in blood, from sarcoidosis patients were increased in number when compared with mDCs from healthy controls. mDCs purified from BAL of sarcoidosis patients induced T cell proliferation and differentiation and did not show diminished immune reactivity. Mo-DCs from patients induced increased TNFα release in co-cultures with naïve allogeneic CD4+ T cells. Finally, immunohistochemical analyses revealed increased numbers of mature CD86+ DCs in granuloma-containing airway mucosal biopsies from sarcoidosis patients.

Conclusion
Taken together, these finding implicate increased local DC activation in granuloma formation or maintenance in pulmonary sarcoidosis.
Adjunctive naturopathic care for type 2 diabetes: patient-reported and clinical outcomes after one year
Authors: Bradley Ryan , Sherman Karen J , Catz Sheryl , Calabrese Carlo , Oberg Erica B , Jordan Luesa , Grothaus Lou , Cherkin Dan 
Published: April 2012

Abstract

Background
Several small, uncontrolled studies have found improvements in self-care behaviors and reductions in clinical risk in persons with type 2 diabetes who received care from licensed naturopathic physicians. To extend these findings and determine the feasibility and promise of a randomized clinical trial, we conducted a prospective study to measure the effects of adjunctive naturopathic care (ANC) in primary care patients with inadequately controlled type 2 diabetes.

Methods
Forty patients with type 2 diabetes were invited from a large integrated health care system to receive up to eight ANC visits for up to one year. Participants were required to have hemoglobin A1c (HbA1c) values between 7.5-9.5 % and at least one additional cardiovascular risk factor (i.e., hypertension, hyperlipidemia or overweight). Standardized instruments were administered by telephone to collect outcome data on self-care, self-efficacy, diabetes problem areas, perceived stress, motivation, and mood. Changes from baseline scores were calculated at 6- and 12-months after entry into the study. Six and 12-month changes in clinical risk factors (i.e., HbA1c, lipid and blood pressure) were calculated for the ANC cohort, and compared to changes in a cohort of 329 eligible, non-participating patients constructed using electronic medical records data. Between-cohort comparisons were adjusted for age, gender, baseline HbA1c, and diabetes medications. Six months was pre-specified as the primary endpoint for outcome assessment.

Results
Participants made 3.9 ANC visits on average during the year, 78 % of which occurred within six months of entry into the study. At 6-months, significant improvements were found in most patient-reported measures, including glucose testing (P = 0.001), diet (P = 0.001), physical activity (P = 0.02), mood (P = 0.001), self-efficacy (P = 0.0001) and motivation to change lifestyle (P = 0.003). Improvements in glucose testing, mood, self-efficacy and motivation to change lifestyle persisted at 12-months (all P < 0.005). For clinical outcomes, mean HbA1c decreased by −0.90 % (P = 0.02) in the ANC cohort at 6-months, a −0.51 % mean difference compared to usual care (P = 0.07). Reductions at 12-months were not statistically significant (−0.34 % in the ANC cohort, P = 0.14; -0.37 % difference compared to the usual care cohort, P = 0.12).

Conclusions
Improvements were noted in self-monitoring of glucose, diet, self-efficacy, motivation and mood following initiation of ANC for patients with inadequately controlled type 2 diabetes. Study participants also experienced reductions in blood glucose that exceeded those for similar patients who did not receive ANC. Randomized clinical trials will be necessary to determine if ANC was responsible for these benefits.
Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission
Authors: Huho Bernadette J , Killeen Gerard F , Ferguson Heather M , Tami Adriana , Lengeler Christian , Charlwood J Derek , Kihonda Aniset , Kihonda Japhet , Kachur S Patrick , Smith Thomas A , Abdulla Salim MK 
Published: April 2012

Abstract

Background
Artemisinin-based combination therapy (ACT) for treating malaria has activity against immature gametocytes. In theory, this property may complement the effect of terminating otherwise lengthy malaria infections and reducing the parasite reservoir in the human population that can infect vector mosquitoes. However, this has never been verified at a population level in a setting with intense transmission, where chronically infectious asymptomatic carriers are common and cured patients are rapidly and repeatedly re-infected.

Methods
From 2001 to 2004, malaria vector densities were monitored using light traps in three Tanzanian districts. Mosquitoes were dissected to determine parous and oocyst rates. Plasmodium falciparum sporozoite rates were determined by ELISA. Sulphadoxine-pyrimethamine (SP) monotherapy was used for treatment of uncomplicated malaria in the contiguous districts of Kilombero and Ulanga throughout this period. In Rufiji district, the standard drug was changed to artesunate co-administered with SP (AS + SP) in March 2003. The effects of this change in case management on malaria parasite infection in the vectors were analysed.

Results

Plasmodium falciparum entomological inoculation rates exceeded 300 infective bites per person per year at both sites over the whole period. The introduction of AS + SP in Rufiji was associated with increased oocyst prevalence (OR [95%CI] = 3.9 [2.9-5.3], p < 0.001), but had no consistent effect on sporozoite prevalence (OR [95%CI] = 0.9 [0.7-1.2], p = 0.5). The estimated infectiousness of the human population in Rufiji was very low prior to the change in drug policy. Emergence rates and parous rates of the vectors varied substantially throughout the study period, which affected estimates of infectiousness. The latter consequently cannot be explained by the change in drug policy.

Conclusions
In high perennial transmission settings, only a small proportion of infections in humans are symptomatic or treated, so case management with ACT may have little impact on overall infectiousness of the human population. Variations in infection levels in vectors largely depend on the age distribution of the mosquito population. Benefits of ACT in suppressing transmission are more likely to be evident where transmission is already low or effective vector control is widely implemented.
Comparison of molecular tests for the diagnosis of malaria in Honduras
Authors: Fontecha Gustavo A , Mendoza Meisy , Banegas Engels , Poorak Mitra , De Oliveira Alexandre M , Mancero Tamara , Udhayakumar Venkatachalam , Lucchi Naomi W , Mejia Rosa E 
Published: April 2012

Abstract

Background
Honduras is a tropical country with more than 70% of its population living at risk of being infected with either Plasmodium vivax or Plasmodium falciparum. Laboratory diagnosis is a very important factor for adequate treatment and management of malaria. In Honduras, malaria is diagnosed by both, microscopy and rapid diagnostic tests and to date, no molecular methods have been implemented for routine diagnosis. However, since mixed infections, and asymptomatic and low-parasitaemic cases are difficult to detect by light microscopy alone, identifying appropriate molecular tools for diagnostic applications in Honduras deserves further study. The present study investigated the utility of different molecular tests for the diagnosis of malaria in Honduras.

Methods
A total of 138 blood samples collected as part of a clinical trial to assess the efficacy of chloroquine were used: 69 microscopically confirmed P. falciparum positive samples obtained on the day of enrolment and 69 follow-up samples obtained 28 days after chloroquine treatment and shown to be malaria negative by microscopy. Sensitivity and specificity of microscopy was compared to an 18 s ribosomal RNA gene-based nested PCR, two single-PCR reactions designed to detect Plasmodium falciparum infections, one single-PCR to detect Plasmodium vivax infections, and one multiplex one-step PCR reaction to detect both parasite species.

Results
Of the 69 microscopically positive P. falciparum samples, 68 were confirmed to be P. falciparum-positive by two of the molecular tests used. The one sample not detected as P. falciparum by any of the molecular tests was shown to be P. vivax-positive by a reference molecular test indicating a misdiagnosis by microscopy. The reference molecular test detected five cases of P. vivax/P. falciparum mixed infections, which were not recognized by microscopy as mixed infections. Only two of these mixed infections were recognized by a multiplex test while a P. vivax-specific polymerase chain reaction (PCR) detected three of them. In addition, one of the day 28 samples, previously determined to be malaria negative by microscopy, was shown to be P. vivax-positive by three of the molecular tests specific for this parasite.

Conclusions
Molecular tests are valuable tools for the confirmation of Plasmodium species and in detecting mixed infections in malaria endemic regions.
Pedometer determined physical activity tracks in African American adults: The Jackson Heart Study
Authors: Newton Robert L , M Hongmei Han , Dubbert Patricia M , Johnson William D , Hickson DeMarc A , Ainsworth Barbara , Carithers Teresa , Taylor Herman , Wyatt Sharon , Tudor-Locke Catrine 
Published: April 2012

Abstract

Background
This study investigated the number of pedometer assessment occasions required to establish habitual physical activity in African American adults.

Methods
African American adults (mean age 59.9 ± 0.60 years; 59 % female) enrolled in the Diet and Physical Activity Substudy of the Jackson Heart Study wore Yamax pedometers during 3-day monitoring periods, assessed on two to three distinct occasions, each separated by approximately one month. The stability of pedometer measured PA was described as differences in mean steps/day across time, as intraclass correlation coefficients (ICC) by sex, age, and body mass index (BMI) category, and as percent of participants changing steps/day quartiles across time.

Results
Valid data were obtained for 270 participants on either two or three different assessment occasions. Mean steps/day were not significantly different across assessment occasions (p values > 0.456). The overall ICCs for steps/day assessed on either two or three occasions were 0.57 and 0.76, respectively. In addition, 85 % (two assessment occasions) and 76 % (three assessment occasions) of all participants remained in the same steps/day quartile or changed one quartile over time.

Conclusion
The current study shows that an overall mean steps/day estimate based on a 3-day monitoring period did not differ significantly over 4 – 6 months. The findings were robust to differences in sex, age, and BMI categories. A single 3-day monitoring period is sufficient to capture habitual physical activity in African American adults.
Competitive DNA transfection formulation via electroporation for human adipose stem cells and mesenchymal stem cells
Authors: Flanagan Michael , Gimble Jeffrey M , Yu Gang , Xia Xueqing , Bunnell Bruce A , Li Shulin 
Published: April 2012

Abstract

Background
Adipose stem cells have a strong potential for use in cell-based therapy, but the current nucleofection technique, which relies on unknown buffers, prevents their use.

Results
We developed an optimal nucleofection formulation for human adipose stem cells by using a three-step method that we had developed previously. This method was designed to determine the optimal formulation for nucleofection that was capable of meeting or surpassing the established commercial buffer (Amaxa), in particular for murine adipose stem cells. By using this same buffer, we determined that the same formulation yields optimal transfection efficiency in human mesenchymal stem cells.

Conclusions
Our findings suggest that transfection efficiency in human stem cells can be boosted with proper formulation.
Roles of Polo-like kinase 3 in suppressing tumor angiogenesis
Authors: Xu Dazhong , Wang Qi , Jiang Yongping , Zhang Yanxi , Vega-SaenzdeMiera Eleazar , Osman Iman , Dai Wei 
Published: April 2012

Abstract
Angiogenesis is essential for promoting growth and metastasis of solid tumors by ensuring blood supply to the tumor mass. Targeting angiogenesis is therefore an attractive approach to therapeutic intervention of cancer. Tumor angiogenesis is a process that is controlled by a complex network of molecular components including sensors, signaling transducers, and effectors, leading to cellular responses under hypoxic conditions. Positioned at the center of this network are the hypoxia-inducible factors (HIFs). HIF-1 is a major transcription factor that consists of two subunits, HIF-1α and HIF-1β. It mediates transcription of a spectrum of gene targets whose products are essential for mounting hypoxic responses. HIF-1α protein level is very low in the normoxic condition but is rapidly elevated under hypoxia. This dramatic change in the cellular HIF-1α level is primarily regulated through the proteosome-mediated degradation process. In the past few years, scientific progress has clearly demonstrated that HIF-1α phosphorylation is mediated by several families of protein kinases including GSK3β and ERKs both of which play crucial roles in the regulation of HIF-1α stability. Recent research progress has identified that Polo-like kinase 3 (Plk3) phosphorylates HIF-1α at two previously unidentified serine residues and that the Plk3-mediated phosphorylation of these residues results in destabilization of HIF-1α. Plk3 has also recently been found to phosphorylate and stabilize PTEN phosphatase, a known regulator of HIF-1α and tumor angiogenesis. Given the success of targeting protein kinases and tumor angiogenesis in anti-cancer therapies, Plk3 could be a potential molecular target for the development of novel and effective therapeutic agents for cancer treatment.